User profiles for "author:Y H Park"

Young Ho Park

Korea National University of Transportation
Verified email at ut.ac.kr
Cited by 1068

A review on MXene synthesis, stability, and photocatalytic applications

G Murali, JK Reddy Modigunta, YH Park, JH Lee… - ACS …, 2022 - ACS Publications
Photocatalytic water splitting, CO2 reduction, and pollutant degradation have emerged as
promising strategies to remedy the existing environmental and energy crises. However …

Identification of Saccharomonospora Strains by the Use of Genomic DNA Fragments and rRNA Gene Probes

JH Yoon, H Kim, SB Kim, HJ Kim… - … of Systematic and …, 1996 - microbiologyresearch.org
Restriction digestion fragments of DNAs extracted from 14 representative strains of
Saccharomonospora azurea,“Saccharomonospora caesia,” Saccharomonospora cyanea …

Inter- and intraspecific phylogenetic analysis of the genus Nocardioides and related taxa based on 16S rDNA sequences

JH Yoon, ST Lee, YH Park - International Journal of …, 1998 - microbiologyresearch.org
The 16S rDNAs from 38 strains of the genus Nocardioides, two Aeromicrobium species and
Terrabacter tumescens were directly sequenced and then analysed. The mean nucleotide …

Antimicrobial effects of silver nanoparticles

JS Kim, E Kuk, KN Yu, JH Kim, SJ Park, HJ Lee… - … , biology and medicine, 2007 - Elsevier
The antimicrobial effects of silver (Ag) ion or salts are well known, but the effects of Ag
nanoparticles on microorganisms and antimicrobial mechanism have not been revealed …

[HTML][HTML] Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer

S Modi, W Jacot, T Yamashita, J Sohn… - … England Journal of …, 2022 - Mass Medical Soc
Background Among breast cancers without human epidermal growth factor receptor 2
(HER2) amplification, overexpression, or both, a large proportion express low levels of …

[HTML][HTML] Trastuzumab deruxtecan versus trastuzumab emtansine for breast cancer

J Cortés, SB Kim, WP Chung, SA Im… - … England Journal of …, 2022 - Mass Medical Soc
Background Trastuzumab emtansine is the current standard treatment for patients with
human epidermal growth factor receptor 2 (HER2)–positive metastatic breast cancer whose …

[HTML][HTML] Event-free survival with pembrolizumab in early triple-negative breast cancer

P Schmid, J Cortes, R Dent, L Pusztai… - … England Journal of …, 2022 - Mass Medical Soc
Background The addition of pembrolizumab to neoadjuvant chemotherapy led to a
significantly higher percentage of patients with early triple-negative breast cancer having a …

Antibacterial Activity and Mechanism of Action of the Silver Ion in Staphylococcus aureus and Escherichia coli

WK Jung, HC Koo, KW Kim, S Shin… - Applied and …, 2008 - Am Soc Microbiol
The antibacterial effect and mechanism of action of a silver ion solution that was electrically
generated were investigated for Staphylococcus aureus and Escherichia coli by analyzing …

[HTML][HTML] Intravascular imaging–guided or angiography-guided complex PCI

JM Lee, KH Choi, YB Song, JY Lee… - … England Journal of …, 2023 - Mass Medical Soc
Background Data regarding clinical outcomes after intravascular imaging–guided
percutaneous coronary intervention (PCI) for complex coronary-artery lesions, as compared …

[HTML][HTML] Pembrolizumab for early triple-negative breast cancer

P Schmid, J Cortes, L Pusztai, H McArthur… - … England Journal of …, 2020 - Mass Medical Soc
Background Previous trials showed promising antitumor activity and an acceptable safety
profile associated with pembrolizumab in patients with early triple-negative breast cancer …